scholarly journals A Case of a Resected Ileosigmoid Knot in an Older Schizophrenic Patient

2016 ◽  
Vol 66 (4) ◽  
pp. 289-292
Author(s):  
Yoichi Okuda ◽  
=Yukio Oshiro ◽  
Tsuyosh Enomoto ◽  
Nobuhiro Ohkohchi
1996 ◽  
Vol 75 (06) ◽  
pp. 978-978 ◽  
Author(s):  
Theodora Glaub ◽  
Bela Telek ◽  
Zoltan Boda ◽  
Sandor Szabo ◽  
Geza Krall ◽  
...  

2016 ◽  
Vol 33 (S1) ◽  
pp. S585-S586
Author(s):  
A.I. Sabau ◽  
P. Cristina ◽  
B. Valerica ◽  
P. Delia Marina

IntroductionSchizophrenia is a severe and complex disease clinically characterized by disturbed thought processes, delusions, hallucinations and reduced social skills. Gene coding for neregulin 1 (NRG 1) located in 8 p21chromosomeand single nucleotide polymorphism (SNPs) have been identified strongly supporting NRG1 gene as a susceptibility gene for schizophrenia.ObjectiveThe present preliminary study, determines the relationship between polymorphism nucleotide sites (SNPs2) of NRG1 gene and schizophrenia.AimsIdentifying rare allele T of neregulin 1 genein schizophrenic patients.MethodWe analyzed the polymorphism (SNPs2) of NRG1 gene in 20 patients recruited from Psychiatry Department of Emergency Clinical Hospital of Arad diagnosed with schizophrenia according to DSM-5-TM and ICD-10 criteria and 10 healthy controls. From all subjects, we obtained 2 mL of peripheral blood samples. Genomic DNA was extracted using the phenol-chloroform method. Genotyping was performed byPCR-based RFLP analysis for all subjects. The obtained PCR product mixture was completely digested with restriction enzyme, separated on SNP1 and SNP2 agarose gel. We present the case of a 31 years old, male, schizophrenic patient with the SNPs2 polymorphism and rare allele T 126.ResultsIn both groups, common allele G 127 and 60 base pairs was identified but only 2 schizophrenic patients presented rare allele T 126 and 30,32 base pairs.ConclusionsThe polymorphism SNPs2 of NRG1 gene with rare allele T 126 and 30,32 base pairs, may play a role in predisposing an individual to schizophrenia. Further and extended replicating studies with multiple sequencing of NRG1 gene are necessary.Disclosure of interestThe authors have not supplied their declaration of competing interest.


2004 ◽  
Vol 6 (3) ◽  
pp. 190-193 ◽  
Author(s):  
Sohtaro Mimasaka ◽  
Masato Funayama ◽  
Masayuki Nata

1974 ◽  
Vol 67 (10) ◽  
pp. 1155-1164 ◽  
Author(s):  
R. H. KAMPMEIER ◽  
BONNIE GRAY ◽  
MAE JORDAN

1963 ◽  
Vol 109 (460) ◽  
pp. 422-427 ◽  
Author(s):  
C. B. Whittaker ◽  
R. M. Hoy

Although phenothiazine drugs have been employed in the treatment of schizophrenia for approximately ten years, we are still uncertain of the best method of using these agents. Whilst the indications to start phenothiazine medication may readily be agreed, the point at which to terminate such therapy remains debatable. Some psychiatrists stop the drug before the patient is discharged from hospital, some at discharge, some shortly after, but an increasing number recommend the schizophrenic patient never to stop taking his phenothiazine. On the other hand, the national drug bill has reached such proportions that some hospitals are now cutting down the administration of phenothiazines, and continue them only in those patients whose improvement is marked and clearly related to the drug.


Sign in / Sign up

Export Citation Format

Share Document